Electromed Inc - Asset Resilience Ratio
Electromed Inc (ELMD) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Electromed Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2018)
This chart shows how Electromed Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Electromed Inc's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Electromed Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Electromed Inc debt and liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Electromed Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Electromed Inc Industry Peers by Asset Resilience Ratio
Compare Electromed Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Electromed Inc (2012–2018)
The table below shows the annual Asset Resilience Ratio data for Electromed Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-06-30 | 0.00% | $0.00 | $26.64 Million | -- |
| 2017-06-30 | 0.00% | $0.00 | $23.06 Million | -- |
| 2016-06-30 | 0.00% | $0.00 | $20.59 Million | -- |
| 2015-06-30 | 0.00% | $0.00 | $17.41 Million | -- |
| 2014-06-30 | 0.00% | $0.00 | $15.79 Million | -- |
| 2013-06-30 | 0.00% | $0.00 | $17.56 Million | -- |
| 2012-06-30 | 0.00% | $0.00 | $20.92 Million | -- |
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as we… Read more